A randomised phase II trial of preoperative chemotherapy of cisplatin–docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204)

Preoperative chemotherapy is a promising strategy in patients with early-stage resectable non-small-cell lung cancer (NSCLC); optimal chemotherapy remains unclear. Clinical (c-) stage IB/II NSCLC patients were randomised to receive either two cycles of docetaxel (D)–cisplatin (P) combination chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunitoh, H, Kato, H, Tsuboi, M, Asamura, H, Tada, H, Nagai, K, Mitsudomi, T, Koike, T, Nakagawa, K, Ichinose, Y, Okada, M, Shibata, T, Saijo, N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538761/
https://www.ncbi.nlm.nih.gov/pubmed/18728643
http://dx.doi.org/10.1038/sj.bjc.6604613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538761/
https://www.ncbi.nlm.nih.gov/pubmed/18728643
http://dx.doi.org/10.1038/sj.bjc.6604613

Ejemplares similares